Abstract:Ethnopharmacological relevance: Ginkgo biloba L. (Ginkgoaceae) is a traditional Chinese medicine known to treating stroke and other cardio-cerebrovascular diseases for thousands of years in China. Ginkgo diterpene lactones (GDL) attracted much attention because of their neuroprotective properties. Aim of the study: To uncover the effects of GDL, which consist of ginkgolide A (GA), ginkgolide B (GB), and ginkgolide K (GK), on ischemic stroke, as well as the underlying molecular mechanisms. Materials and methods: We used middle cerebral artery occlusion/reperfusion (MCAO/R) and oxygen-glucose deprivation/reoxygenation (OGD/R) models mimicking the process of ischemia/reperfusion in vivo and in vitro, respectively. Anticoagulant effects of GDL were investigated on platelet activating factor (PAF), arachidonic acid (AA) and adenosine diphosphate (ADP)-induced platelet aggregation both in vivo and in vitro. We also evaluated the effects of GDL on lipopolysaccharide (LPS)-induced inflammatory response in primary cultured rats' astrocytes. Infarct size, neurological deficit score, and brain edema were measured at 72h after MCAO. Immunohistochemistry was utilized to analyze neurons necrosis and astrocytes activation. Expression of proinflammatory cytokines, including tumor necrotic factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) were detected using enzyme-linked immunosorbent assay (ELISA) and real time PCR. The levels of toll-like receptor 4 (TLR4) and nuclear factor kappa B (NF-kappa B) were assessed by real time PCR or Western blot. Results: Compared with MCAO/R rats, GDL significantly reduced infarct size and brain edema, improved neurological deficit score. Meanwhile, GDL suppressed platelet aggregation, astrocytes activation, pro-inflammatory cytokines releasing, TLR4 mRNA expression and transfer of NF-kappa B from cytoplasm to nucleus. Furthermore, GDL alleviated OGD/R injury and LPS-induced inflammatory response in primary astrocytes, characterized by promoting cell viability, decreasing lactate dehydrogenase (LDH) activity, and inhibiting IL-1 beta and TNF-alpha releasing. Conclusions: In summary, GDL attenuate cerebral ischemic injury, inhibit platelet aggregation and astrocytes activation. The anti-inflammatory activity might be associated with the downregulation of TLR4/NF-kappa B signal pathway. Our present findings provide an innovative insight into the novel treatment of GDL in ischemic stroke therapy.

Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs.

Ginkgolide B Functions As a Determinant Constituent of Ginkgolides in Alleviating Lipopolysaccharide-Induced Lung Injury

Ginkgetin effectively mitigates collagen and AA‐induced platelet activation via PLCγ2 but not cyclic nucleotide‐dependent pathway in human

Ginkgo Biloba Inhibits Intermittent High Glucose Induced Monocyte Adhesion to Endothelial Cells by Decreasing Adhesion Molecules Expression Via Antioxidant Activity

Ginkgolide B Inhibits Platelet and Monocyte Adhesion in TNFα-treated HUVECs under Laminar Shear Stress

Ginkgo Diterpene Lactones Inhibit Cerebral Ischemia/reperfusion Induced Inflammatory Response in Astrocytes Via TLR4/NF-κB Pathway in Rats.

Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality

Ginkgolide A Ameliorates LPS-Induced Inflammatory Responses in Vitro and in Vivo.

Ginkgolide B Promotes Cell Growth in Endothelial Progenitor Cells Through Mir-126 and the Akt Signaling Pathway

Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling

Activity of Ginkgo Biloba Extract and Quercetin on Thrombomodulin Expression and Tissue-Type Plasminogen Activator Secretion by Human Umbilical Vein Endothelial Cells

The Protective Effect of Tetrahydroxystilbene Glucoside on High Glucose-Induced Injury in Human Umbilical Vein Endothelial Cells Through the PI3K/Akt/eNOS Pathway and Regulation of Bcl-2/Bax

Anti-inflammatory Action of Ginkgo Biloba Leaf Polysaccharide Viatlr4/nf-?B Signaling Suppression.

[Antagonistic effect of ginkgolide homologues on PAF-induced platelet aggregation and neuroprotective effect]

Protective Effects of 6-Gingerol on Vascular Endothelial Cell Injury Induced by High Glucose Via Activation of PI3K-AKT-eNOS Pathway in Human Umbilical Vein Endothelial Cells.

Ginkgolide B Enhances the Differentiation of Preosteoblastic MC3T3-E1 Cells Through VEGF: Involvement of the P38 MAPK Signaling Pathway.

Ginkgo Biloba Extract Ameliorates Hyperglycaemia-Induced Enteric Glial Cell Injury Via Regulation of the TLR2-related Pathway.

The Lipophilic Extract from Ginkgo Biloba L. Leaves Promotes Glucose Uptake and Alleviates Palmitate-Induced Insulin Resistance in C2C12 Myotubes

Anti-atherosclerotic Effects and Molecular Targets of Ginkgolide B from Ginkgo Biloba

Comparing the Role of Ginkgolide B and Ginkgolide K on Cultured Astrocytes Exposed to Oxygen‑glucose Deprivation.

Ginkgo Biloba Leaf Extract Prevents Diabetic Nephropathy Through the Suppression of Tissue Transglutaminase